Therapeutic Antibodies for Cancer Part 1 Flashcards

1
Q

Define Tumor Targeting Antibodies

A

Monoclonal antibody designed to target oncoproteins expressed by tumor cells and to cause an immune response that destroys cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define Immunomodulatory Antibody:

A

Monoclonal antibodies specifically interacts with immuno-regulatory molecules, which elicits or restores an existing anti-cancer immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define Adoptive T cell Transfer:

A

A treatment using host T cells to boost the natural ability of immune activity to fight cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define Immunostimulatory Cytokines:

A

Multiple functional proteins that play important roles in body’s immune responses and have the immune-regulatory activity to control cancer cell growth. The two main types of cytokines used to treat cancer are interferon-α/β and interleukin-2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define Cancer-Therapeutic Vaccines:

A

Antigen-presenting cells (APC) to stimulate immune response against cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define Innate Immunity Agonists:

A

Bacillus Calmette-Guérin (BCG): An innate immunity-stimulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define Monoclonal Antibodies (mAbs):

A

Produced from a single B lymphocytes, either from mouse, human or other species.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define Murine mAbs

A

Derived entirely from mouse, usually mouse hybridoma cells by the fusion of mouse myeloma cells with spleen B-cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define Chimeric mAbs:

A

Variable regions derived from a murine source and the constant regions derived from a human source.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define Humanized mAbs:

A

Antigen-binding sequences (CDRs) derived from a mouse and all others from a human source. (less mouse, more human)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define Human mAbs:

A

Derived entirely from a human source

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define Naked Therapeutic Antibody

A

Simple antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define Conjugated Therapeutic Antibody

A

Antibody carrying chemotherapy or isotopes (ADC or AIC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Define Immuno-Regulatory Therapeutic Antibody

A

Remove the inhibitory signals and restore T cell response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define Bispecific Antibody

A

One side interacts with T cell immune response and the other carries chemotherapy or isotopes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Immuno-Regulatory Therapeutic Antibody Drugs

A

Ipilimumab (CTLA-4 inhibitor)

Nivolumab and pembrolizumab (PD-1 inhibitor)

17
Q

Naked Antibody Drugs

A

Trastuzumab (HER2)

Cetuximab (EGFR)

18
Q

ADC Drugs

A

Ado-Trastuzumab emansine (HER2)

19
Q

When EGFR is activated…

A

it will increase the oncogenic cell signals to make the cell proliferate a lot faster or metastasis much more aggressive (so if you block this you can treat cancer

20
Q

Transtuzumab Brand Name, Antibody Type and Target

A

Herceptin
Humanized mouse mAb
HER2

21
Q

Transtuzumab Indication

A

Adjuvant breast cancer

Metastatic Breast Cancer

22
Q

Transtuzumab AE

A

Cardiomyopathy

Pulmonary toxicity

23
Q

Cetuximab Brand Name, Antibody Type and Target

A

Erbitux
Chimeric mAb
EGFR

24
Q

Cetuximab Indication

A

Head and Neck Cancer

Colorectal Cancer WITHOUT KRAS mutation

25
KRAS mutation leads to
Upon activation through mutation, it causes increased proliferation and no longer needs EGFR to activate it
26
Cetuximab AE
Cardiopulmonary Pulmonary toxicity Dermatologic toxicity
27
Ado-Trastuzumab Ematansine (T-DM1) Brand Name, Antibody Type and Target
Kadcyla Humanized mAb conjugated with a highly potent chemical maytansinoid (DM1) HER2
28
T-DM1 Indication
HER2 Positive Metastatic Breast Cancer
29
T-DM1 AE
Hepatoxicity Cardiotoxicity Embryo-fetal toxicity
30
Bevacizumab Brand Name, Antibody Type and Target
Avastin Humanized mAb Specific for VEGF not the receptor
31
Bevacizumab Indication
* Metastatic colorectal cancer * Non-squamous non-small cell lung cancer * Glioblastoma * Metastatic renal cell carcinoma
32
Bevacizumab AE
GI performation Wound healing complication Hemorrhage
33
What is the purpose of VEGF
Regulate/stimulate new blood vessel production